Literature DB >> 9260736

Result of long-term administration of L-threo-3,4-dihydroxyphenylserine in patients with pure akinesia as an early symptom of progressive supranuclear palsy.

M Yamamoto1, S Fujii, Y Hatanaka.   

Abstract

Results of long-term administration of L-threo-3,4-dihydroxyphenylserine (L-DOPS), a synthetic precursor of noradrenaline, in a patient with freezing gait and pure akinesia are reported. Effects were temporal and disappeared during a 16-month treatment period. It was recognized that pure akinesia is an early symptom of progressive supranuclear palsy (PSP). Previously, we reported results of short-term (4 weeks) administration of L-DOPS in this patient. We present the further clinical course of the patient, along with results of long-term (16 months) administration of L-DOPS.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9260736     DOI: 10.1097/00002826-199708000-00010

Source DB:  PubMed          Journal:  Clin Neuropharmacol        ISSN: 0362-5664            Impact factor:   1.592


  2 in total

1.  Pure akinesia: a kinematic analysis in a case responsive to rotigotine.

Authors:  R Di Fabio; M Serrao; F Pierelli; G Fragiotta; G Sandrini
Journal:  Funct Neurol       Date:  2013 Apr-May

2.  Current and future treatments in progressive supranuclear palsy.

Authors:  Irene van Balken; Irene Litvan
Journal:  Curr Treat Options Neurol       Date:  2006-05       Impact factor: 3.598

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.